Royal Bank of Canada’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25
| Closed | – | – | 7265 |
|
|
2024
Q1 | $0 | Buy |
+25
| New | – | ﹤0.01% | 7205 |
|
|
2023
Q1 | – | Sell |
-26
| Closed | -$1K | – | 7084 |
|
|
2022
Q4 | $1K | Sell |
26
-250
| -91% | -$9.62K | ﹤0.01% | 6652 |
|
|
2022
Q3 | $6K | Hold |
276
| – | – | ﹤0.01% | 6196 |
|
|
2022
Q2 | $6K | Buy |
276
+250
| +962% | +$5.44K | ﹤0.01% | 6140 |
|
|
2022
Q1 | $1K | Hold |
26
| – | – | ﹤0.01% | 7158 |
|
|
2021
Q4 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 7036 |
|
|
2020
Q3 | – | Sell |
-385
| Closed | -$11K | – | 6453 |
|
|
2020
Q2 | $11K | Buy |
+385
| New | +$11K | ﹤0.01% | 5335 |
|